John Riley, DO
Facial Plastic Surgery · Grand Rapids, MINPI 1629573662
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,355 of the $2,929 with a category attached, or 80.4%. Stryker accounts for 64.0% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $1,468, 6.2 times the $235 reported in 2021.
Across 41 payments — averaging $71.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Regeneron Healthcare Solutions, Inc.$318
- Medtronic$282
- Intersect ENT, Inc.$144
- Sanofi$105
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$61
- plus $146 from 5 others
What the payments were for
- Travel & lodging$57320%
- Food & beverage$2,35580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 19 | $1,873 |
| Regeneron Healthcare Solutions, Inc. | 5 | $318 |
| Medtronic | 3 | $282 |
| Intersect ENT, Inc. | 1 | $144 |
| Sanofi | 4 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $61 |
| Inspire Medical Systems, Inc. | 2 | $53 |
| Integra Lifesciences Corporation | 1 | $29 |
| Neurent Medical Limited | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| GSK | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MEDLINE INDUSTRIES, INC.$593
- SCOPIS ENT$509
- XPRESS LOPROFILE$440
- DUPIXENT$235
- SINUVA$144
- PROPEL$140
- PTeye$114
How this compares
$2,929 in reported general payments places this provider in the 65th percentile of 30 facial plastic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 160 | $3,632 |
| Ipratropium Bromide | 97 | $3,103 |
| Omeprazole | 78 | $1,120 |
| Doxycycline Monohydrate | 48 | $712 |
| Famotidine | 57 | $692 |
| Ofloxacin | 24 | $381 |
| Pantoprazole Sodium | 17 | $301 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 27 | $289 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $288 |
| Prednisone | 67 | $226 |
| Fluticasone Propionate | 13 | $149 |
| Methylprednisolone | 21 | $123 |
| Mupirocin | 21 | $122 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $77 |
| Amoxicillin | 14 | $28 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Grand Rapids
- Andrew BehlerGrand Rapids$10K
- Anthony HowardGrand Rapids$4K
- James SpotoGrand Rapids$2K
- Ahmed MakiPontiac$24K
- Casey AshbyFarmington Hills$15K
- Christopher MetzMadison Heights$7K
- John UlrichGrand Blanc$7K
- Laura Garcia RodriguezDetroit$6K
- Noah SternDetroit$4K
- Adam RourkeSterling Heights$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.